Literature DB >> 15107500

Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.

Brent Segelke1, Mark Knapp, Saloumeh Kadkhodayan, Rod Balhorn, Bernhard Rupp.   

Abstract

Clostridium botulinum neurotoxins (BoNTs), the most potent toxins known, disrupt neurotransmission through proteolysis of proteins involved in neuroexocytosis. The light chains of BoNTs are unique zinc proteases that have stringent substrate specificity and require exceptionally long substrates. We have determined the crystal structure of the protease domain from BoNT serotype A (BoNT/A). The structure reveals a homodimer in a product-bound state, with loop F242-V257 from each monomer deeply buried in its partner's catalytic site. The loop, which acts as a substrate, is oriented in reverse of the canonical direction for other zinc proteases. The Y249-Y250 peptide bond of the substrate loop is hydrolyzed, leaving the Y249 product carboxylate coordinated to the catalytic zinc. From the crystal structure of the BoNT/A protease, detailed models of noncanonical binding and proteolysis can be derived which we propose are also consistent with BoNT/A binding and proteolysis of natural substrate synaptosome-associated protein of 25 kDa (SNAP-25). The proposed BoNT/A substrate-binding mode and catalytic mechanism are markedly different from those previously proposed for the BoNT serotype B.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107500      PMCID: PMC406437          DOI: 10.1073/pnas.0400584101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Questions about the structure of the botulinum neurotoxin B light chain in complex with a target peptide.

Authors:  B Rupp; B Segelke
Journal:  Nat Struct Biol       Date:  2001-08

2.  Enzymatic autocatalysis of botulinum A neurotoxin light chain.

Authors:  S A Ahmed; M P Byrne; M Jensen; H B Hines; E Brueggemann; L A Smith
Journal:  J Protein Chem       Date:  2001-04

3.  Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.

Authors:  M A Hanson; R C Stevens
Journal:  Nat Struct Biol       Date:  2000-08

4.  Cloning, expression, and one-step purification of the minimal essential domain of the light chain of botulinum neurotoxin type A.

Authors:  S Kadkhodayan; M S Knapp; J J Schmidt; S E Fabes; B Rupp; R Balhorn
Journal:  Protein Expr Purif       Date:  2000-06       Impact factor: 1.650

Review 5.  Botulinum neurotoxins: mode of action and detection.

Authors:  M Wictome; C C Shone
Journal:  Symp Ser Soc Appl Microbiol       Date:  1998

6.  Crystal structure of botulinum neurotoxin type A and implications for toxicity.

Authors:  D B Lacy; W Tepp; A C Cohen; B R DasGupta; R C Stevens
Journal:  Nat Struct Biol       Date:  1998-10

7.  Endoproteinase activity of type A botulinum neurotoxin: substrate requirements and activation by serum albumin.

Authors:  J J Schmidt; K A Bostian
Journal:  J Protein Chem       Date:  1997-01

8.  Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A.

Authors:  H Kurazono; S Mochida; T Binz; U Eisel; M Quanz; O Grebenstein; K Wernars; B Poulain; L Tauc; H Niemann
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

9.  Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.

Authors:  C C Shone; A K Roberts
Journal:  Eur J Biochem       Date:  1994-10-01

10.  SNARE motif and neurotoxins.

Authors:  O Rossetto; G Schiavo; C Montecucco; B Poulain; F Deloye; L Lozzi; C C Shone
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

View more
  29 in total

Review 1.  Microbe hunting.

Authors:  W Ian Lipkin
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

2.  Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.

Authors:  Joseph W Arndt; Wayne Yu; Fay Bi; Raymond C Stevens
Journal:  Biochemistry       Date:  2005-07-19       Impact factor: 3.162

Review 3.  Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.

Authors:  B R Singh
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

4.  Botulinum neurotoxin light chain refolds at endosomal pH for its translocation.

Authors:  Shuowei Cai; Roshan Kukreja; Sue Shoesmith; Tzuu-Wang Chang; Bal Ram Singh
Journal:  Protein J       Date:  2006-12       Impact factor: 2.371

5.  SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.

Authors:  Rakhi Agarwal; Subramanyam Swaminathan
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

6.  Bimodal modulation of the botulinum neurotoxin protein-conducting channel.

Authors:  Audrey Fischer; Yuya Nakai; Lisa M Eubanks; Colin M Clancy; William H Tepp; Sabine Pellett; Tobin J Dickerson; Eric A Johnson; Kim D Janda; Mauricio Montal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

Review 7.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

8.  Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A.

Authors:  Alan R Jacobson; Michael Adler; Nicholas R Silvaggi; Karen N Allen; Genessa M Smith; Ross A Fredenburg; Ross L Stein; Jong-Beak Park; Xiaochuan Feng; Charles B Shoemaker; Sharad S Deshpande; Michael C Goodnough; Carl J Malizio; Eric A Johnson; Sabine Pellett; William H Tepp; Saul Tzipori
Journal:  Toxicon       Date:  2017-07-08       Impact factor: 3.033

Review 9.  Interaction of botulinum toxin with the epithelial barrier.

Authors:  Yukako Fujinaga
Journal:  J Biomed Biotechnol       Date:  2010-02-14

10.  The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.

Authors:  Rahman M Mizanur; Verna Frasca; Subramanyam Swaminathan; Sina Bavari; Robert Webb; Leonard A Smith; S Ashraf Ahmed
Journal:  J Biol Chem       Date:  2013-06-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.